This interaction results in upregulation of specificity protein 1 (SP1), a transcription factor that causes aberrant expression of the MMR-associated protein, MSH6.19 Taken together, the result suggests GBM cells with elevated XIST may exhibit decreased TMZ sensitivity due to the abnormal MSH6 expression. Here, SP1 is linked to glioblastoma.